Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTP study of 5 versus 10 days of fluoroquinolone therapy for uncomplicated community-acquired acute pyelonephritis in young women
2008-004571-22Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2008
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levofloxacin, ofloxacin and ciprofloxacin in acute pyelonephritis (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Clinical and microbiological success at 30 days after end of effective antibiotic therapy, Clinical cure rate at 30 days after end of antibiotic therapy and 1 more. Started Sep 2008; status: active.
02
Drugs
levofloxacinofloxacinciprofloxacin
03
Conditions
acute pyelonephritis
Beyond the preview
Go deeper on 2008-004571-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004571-22.